Abbott Laboratories ABT
NYSE ABT
$96.70 -2.13 (-2.16%)
As of: Oct 1, 2026 · 3:59 PM EDT

Abbott Laboratories (ABT) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Abbott Laboratories (ABT) recorded Liabilities and Shareholders Equity of $109.22 billion in Q2 2026, up 30.0% from $84 billion a year earlier but down 1.1% from the prior quarter.

Analysis

Abbott Laboratories (ABT) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Abbott Laboratories reported Liabilities and Shareholders Equity of $86.71 billion, up 6.5% from FY2024.

  • Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $81.41 billion in FY2024 (+11.2%), $73.21 billion in FY2023 (-1.6%), $74.44 billion in FY2022 (-1.0%) and $75.2 billion in FY2021 (+3.6%).
  • Quarterly Liabilities and Shareholders Equity has ranged from $72.09 billion in Q3 2023 to $110.43 billion in Q1 2026 over the past five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased for eight consecutive quarters, with growth averaging 15.9% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 35.6% in Q1 2026, against a decline of 1.8% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $110.43 billion (Q1 2026), $86.71 billion (Q4 2025) and $84.18 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 109.22 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 93.31 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 50.73 Bn
10 Agilent Technologies 48.58 Bn 41.47 Bn 1.04 Bn 13.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 109.22 Bn
Mar 31, 2026 110.43 Bn
Dec 31, 2025 86.71 Bn
Sep 30, 2025 84.18 Bn
Jun 30, 2025 84.00 Bn
Mar 31, 2025 81.45 Bn
Dec 31, 2024 81.41 Bn
Sep 30, 2024 74.36 Bn
Jun 30, 2024 73.02 Bn
Mar 31, 2024 72.47 Bn
Dec 31, 2023 73.21 Bn
Sep 30, 2023 72.09 Bn
Jun 30, 2023 73.35 Bn
Mar 31, 2023 73.79 Bn
Dec 31, 2022 74.44 Bn
Sep 30, 2022 72.80 Bn
Jun 30, 2022 74.20 Bn
Mar 31, 2022 74.01 Bn
Dec 31, 2021 75.20 Bn
Sep 30, 2021 73.80 Bn
API Access

Abbott Laboratories Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ABT&period=max&api_key=YOUR_API_KEY